Human IkB-alpha quantitates human IkB-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IkB-alpha.
Accession number
Ai462015 ; CEI-6 ; CEI-6/IkBa ; I kappa B-alpha ; I(Kappa)B(alpha) ; I79_018146 ; IkappaB alpha ; IkappaBalpha ; I-kappaBalpha ; I-kappa-B-alpha ; IkBa ; IkBalpha ; IKB-alpha ; Inhibiteur du facteur nucléaire de l’activateur génétique de la chaîne légère kappa dans les cellules B alpha ; Inhibiteur du facteur nucléaire de l’activateur génétique de la chaîne légère kappa dans les cellules B, alpha ; MAD3 ; MAD-3 ; Inhibiteur majeur de la protéine liant l’activateur MAD3 ; inhibiteur NF kappa B alpha ; inhibiteur NF-kappaB Inhibiteur de NFKB alpha ; NFKBI ; Nfkbia ; facteur nucléaire de l’activateur génétique de la chaîne légère kappa dans les cellules B ; facteur nucléaire de l’activateur génétique de la chaîne légère kappa dans l’inhibiteur des cellules B, alpha ; facteur nucléaire de l’activateur génétique du polyp léger kappa dans la cellule B 1 ; facteur nucléaire de l’activateur génétique du polypeptide l
Dose range
0.65 to 150 ng/mL
Sensitivity of the dosage
0.65 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human IkB-alpha quantitates human IkB-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IkB-alpha.
Human IkB-alpha quantitates human IkB-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IkB-alpha.
The IkB-alpha is a 40 kDa protein that works to inhibit NF-kappaB activity. Inhibition occurs by protein-protein interaction between I kappaB proteins and NF-kappaB dimers in cytosol. The interaction of I kappa B-alpha with NF-kappaB masks the nuclear localization sequence of NF-kappaB, thus preventing the translocation of NF-kappaB to the nucleus. A variety of stimuli can activate genetic expression by releasing NF-kappaB by degradation of I kappaB alpha. These stimuli include proinflammatory cytokines TNF-alpha and IL-beta, chemokines, PMA, growth factors, LPS, UV irradiation, viral infection, as well as various chemical and physical stresses. In humans, the gene is found on the q arm of the chromosome. NFkB activation requires that IkB be phosphorylated on specific serine residues, resulting in targeted degradation of IkB. The IkB kinase alpha (IKK alpha), previously known as CHUK, interacts with the IkB-alpha and phosphoryl specifically l的IkB-alpha at sites that trigger its degradation (serine and ). The IKK alpha appears to play an essential role in the activation of NFkB in response to proinflammatory cytokines. IkB phosphorylation by IKK alpha is stimulated by NFkB (NIK) kinase, which is itself a central regulator for NFkB activation in response to TNF and IL-. The IKK functional complex contains three subunits, IKK alpha, IKK beta, and IKK gamma, each of which appears to make essential contributions to the phosphorylation of IkB.
Sensitivity
Sensitivity of the dosage: 0.65 ng/mL.
Measurement range
Dose range: 0.65 to 150 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: IkB alpha.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17154543
Specifications
Accession number
Ai462015; CEI-6; CEI-6/IkBa; I kappa B-alpha; I(Kappa)B(alpha); I79_018146; IkappaB alpha; IkappaBalpha; I-kappaBalpha; I-kappa-B-alpha; IkBa; IkBalpha; IKB-alpha; Inhibitor of the nuclear factor of the light kappa chain genetic activator in B alpha cells; Inhibitor